Mylan shareholders approve hostile takeover
Drug maker Mylan’s shareholders have voted in favour of a $33bn bid for Perrigo, the company announced.
MYLAN
n/a
n/a
n/a
n/a
Mylan Inc.
$0.00
19:30 08/12/22
0.00%
$0.00
Nasdaq 100
17,526.80
12:15 24/04/24
0.32%
55.33
While Perrigo’s management were against the deal, its fate lies in the hands of Perrigo’s investors.
Mylan executive chairman said in an announcement it would launch a formal offer to acquire the counter drug maker Perrigo in the “coming weeks.”
Shares in Nasdaq listed Mylan were down by 0.95% in pre-market trading.